Gene Expression Profiling in Head and Neck Cancer
Author Information
Author(s): Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, Muller D, Marchal P, Zhao C, Melle D, Bracco L, Abecassis J, Wasylyk B
Primary Institution: Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP
Hypothesis
The study aims to identify novel genes associated with head and neck squamous cell carcinoma (HNSCC) through differential expression profiling.
Conclusion
The study identified a series of novel genes that exhibit significant differences in expression between HNSCC tumors and normal matched tissues.
Supporting Evidence
- Over 70% of HNSCC patients present with advanced disease.
- Less than 30% of HNSCC patients are disease-free after 3 years.
- Identified genes may serve as potential biomarkers for diagnosis and treatment.
Takeaway
Researchers looked at the genes in tumors from patients with throat cancer and found new genes that could help understand the disease better.
Methodology
The study used PCR differential display to analyze gene expression in tumor and normal tissues from patients with HNSCC.
Limitations
The study was limited by the small sample size and the focus on a specific site of HNSCC.
Participant Demographics
Patients with hypopharyngeal tumors, not previously treated at the time of surgery.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website